| IHA | idiopathic hyperaldosteronism; indirect hemagglutination; indirect hemagglutination antibody |
|---|---|
| HI antibody | Hemagglutination Inhibiting antibody; Ç÷±¸ ÀÀÁý ¾ïÁ¦ Ç×ü |
| HI Method | Hemagglutination Inhibiting Method; Ç÷±¸ ÀÀÁý ¾ïÁ¦¹ý |
| MHA-TP | Micro-Hemagglutination Assay for antibodies to Treponema Pallidum |
| CCH | C-cell hyperplasia; chronic chloride hemagglutination; chronic cholestatic hepatitis |
| HIT | Hemagglutination inhibition test |
|---|---|
| IAHA | Immune adherence hemagglutination |
| IHA | Indirect Hemagglutination assay |
| PHA | Passive hemagglutination assays |
| hemagglutination | <haematology> Agglutination of red blood cells, often used to test for the presence of antibodies directed against red cell surface antigens or carbohydrate binding proteins or viruses in a solution. Requires that the agglutinin has at least two binding sites. (18 Nov 1997) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|